Initially, we examined changes in the expression levels of claudin-1 and claudin-3 after EGF treatment in two colorectal adenocarcinoma cell lines, Caco-2 and HT-29, which differ in differentiation status and metastatic potential. This evidence concerns the gene EGF and colorectal adenocarcinoma.